Yahoo Finance Video
In his first week back in office, President Trump rolled back a Biden-era executive order aimed at reducing prescription drug costs for Medicare patients, including a proposed $2 drug list for common generics. Yahoo Finance Senior Reporter Jordan Weissman joins Wealth to explain that the program, meant to save US seniors a combined $2 billion annually, was never implemented and is now scrapped. Trump’s decision reflects ideological differences over Medicare management, leaving questions about how his administration will handle upcoming drug price negotiations with Medicare. To watch more expert insights and analysis on the latest market action, check out more Wealth here. This post was written by Josh Lynch